CYP 3.85% 25.0¢ cynata therapeutics limited

Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial, page-178

  1. 19,875 Posts.
    lightbulb Created with Sketch. 1010

    For all the talk of msb on this thread the fact remains. They trade more than 30,000 volume and the retail market investors know they exist. Cynata is great buying at this level, but no one seems to care. I think we have seven years of ‘discussion fatigue’
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.